BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2024 7:12:19 AM | Browse: 96 | Download: 357
 |
Received |
|
2024-03-22 22:33 |
|
Peer-Review Started |
|
2024-03-22 22:33 |
|
First Decision by Editorial Office Director |
|
2024-05-01 06:04 |
|
Return for Revision |
|
2024-05-04 13:21 |
|
Revised |
|
2024-05-29 21:51 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-08-05 02:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-08-05 07:05 |
|
Articles in Press |
|
2024-08-05 07:05 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-10-09 08:03 |
|
Publish the Manuscript Online |
|
2024-10-14 07:12 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Minireviews |
| Article Title |
Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Karolina Rzeniewicz and Rohini Sharma |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rohini Sharma, Doctor, FRACP, MBBS, Professor, Senior Lecturer, Department of Surgery and Cancer, Hammersmith Hospital, 72 Du Cane Road, London W12 0NN, United Kingdom. r.sharma@imperial.ac.uk |
| Key Words |
Pathophysiology; Targeted therapy; Immunotherapy; Systemic anti-cancer therapy; Non-alcoholic fatty liver disease; Hepatocellular carcinoma |
| Core Tip |
Hepatocellular carcinoma (HCC) arising on a background of non-alcoholic fatty liver disease (NAFLD) is not well understood but patients tend to have poorer prognosis vs those with other HCC aetiologies. Currently all HCC patients are treated the same regardless of aetiology, and understanding of best treatment options for the NAFLD-HCC population is an urgent clinical need. This narrative review discusses NAFLD-HCC screening, pathophysiology, systemic treatment, and offers suggestions for future directions in this therapy area. |
| Publish Date |
2024-10-14 07:12 |
| Citation |
Rzeniewicz K, Sharma R. Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease. World J Clin Oncol 2024; 15(11): 1394-1403 |
| URL |
https://www.wjgnet.com/2218-4333/full/v15/i11/1394.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v15.i11.1394 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
